Literature DB >> 20346767

ALPS-ten lessons from an international workshop on a genetic disease of apoptosis.

Michael J Lenardo1, João B Oliveira, Lixin Zheng, V Koneti Rao.   

Abstract

An international group of researchers investigating the molecular, cellular, immunological, and clinical aspects of the autoimmune lymphoproliferative syndrome (ALPS) met in Bethesda, Maryland on September 21-22, 2009 to discuss advances made over the past 15 years. Their discussions yielded ten broad messages applicable to genetic and immunological investigations of human disease.

Entities:  

Mesh：

Year:  2010        PMID： 20346767      PMCID： PMC2858867          DOI： 10.1016/j.immuni.2010.03.013

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  15 in total

1.  Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Dana A Obzut; Kelly Axsom; John K Choi; Kelly C Goldsmith; Junior Hall; Jessica Hulitt; Catherine S Manno; John M Maris; Nicholas Rhodin; Kathleen E Sullivan; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

2.  The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Authors:  S E Straus; E S Jaffe; J M Puck; J K Dale; K B Elkon; A Rösen-Wolff; A M Peters; M C Sneller; C W Hallahan; J Wang; R E Fischer; C E Jackson; A Y Lin; C Bäumler; E Siegert; A Marx; A K Vaishnaw; T Grodzicky; T A Fleisher; M J Lenardo
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

3.  FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.

Authors:  Hidenobu Takahashi; Friedrich Feuerhake; Jeffery L Kutok; Stefano Monti; Paola Dal Cin; Donna Neuberg; Jon C Aster; Margaret A Shipp
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

4.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Authors:  Helen Su; Nicolas Bidère; Lixin Zheng; Alan Cubre; Keiko Sakai; Janet Dale; Leonardo Salmena; Razqallah Hakem; Stephen Straus; Michael Lenardo
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

5.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

6.  Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

Authors:  Eliska Holzelova; Cédric Vonarbourg; Marie-Claude Stolzenberg; Peter D Arkwright; Françoise Selz; Anne-Marie Prieur; Stéphane Blanche; Jirina Bartunkova; Etienne Vilmer; Alain Fischer; Françoise Le Deist; Frédéric Rieux-Laucat
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

7.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Authors:  Andrew L Snow; Rebecca A Marsh; Scott M Krummey; Philip Roehrs; Lisa R Young; Kejian Zhang; Jack van Hoff; Deepali Dhar; Kim E Nichols; Alexandra H Filipovich; Helen C Su; Jack J Bleesing; Michael J Lenardo
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

8.  Pathological findings in human autoimmune lymphoproliferative syndrome.

Authors:  M S Lim; S E Straus; J K Dale; T A Fleisher; M Stetler-Stevenson; W Strober; M C Sneller; J M Puck; M J Lenardo; K S Elenitoba-Johnson; A Y Lin; M Raffeld; E S Jaffe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Authors:  F Rieux-Laucat; F Le Deist; C Hivroz; I A Roberts; K M Debatin; A Fischer; J P de Villartay
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

10.  Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.

Authors:  Rita Clementi; Annalisa Chiocchetti; Giuseppe Cappellano; Elisa Cerutti; Massimo Ferretti; Elisabetta Orilieri; Irma Dianzani; Marina Ferrarini; Marco Bregni; Cesare Danesino; Valeria Bozzi; Maria Caterina Putti; Franco Cerutti; Angela Cometa; Franco Locatelli; Rita Maccario; Ugo Ramenghi; Umberto Dianzani
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113
View more
  12 in total

1.  NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.

Authors:  Feiyan Liu; Kankana Bardhan; Dafeng Yang; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Kebin Liu
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

3.  A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.

Authors:  Bernice Lo; Madhu Ramaswamy; Joie Davis; Susan Price; V Koneti Rao; Richard M Siegel; Michael J Lenardo
Journal:  J Clin Immunol       Date:  2012-10-11       Impact factor: 8.317

4.  Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

Authors:  Susan Price; Pamela A Shaw; Amy Seitz; Gyan Joshi; Joie Davis; Julie E Niemela; Katie Perkins; Ronald L Hornung; Les Folio; Philip S Rosenberg; Jennifer M Puck; Amy P Hsu; Bernice Lo; Stefania Pittaluga; Elaine S Jaffe; Thomas A Fleisher; V Koneti Rao; Michael J Lenardo
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

5.  Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.

Authors:  Dafeng Yang; Christina M Torres; Kankana Bardhan; Mary Zimmerman; Tracy L McGaha; Kebin Liu
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

Review 6.  Clues to immune tolerance: the monogenic autoimmune syndromes.

Authors:  Michael Waterfield; Mark S Anderson
Journal:  Ann N Y Acad Sci       Date:  2010-10-22       Impact factor: 5.691

7.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

8.  The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.

Authors:  Gabor Koncz; Anne-Odile Hueber
Journal:  Front Immunol       Date:  2012-07-25       Impact factor: 7.561

9.  Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.

Authors:  Maurizio Aricò; Elena Boggio; Valentina Cetica; Matteo Melensi; Elisabetta Orilieri; Nausicaa Clemente; Giuseppe Cappellano; Sara Buttini; Maria Felicia Soluri; Cristoforo Comi; Carlo Dufour; Daniela Pende; Irma Dianzani; Steven R Ellis; Sara Pagliano; Stefania Marcenaro; Ugo Ramenghi; Annalisa Chiocchetti; Umberto Dianzani
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

Review 10.  Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies.

Authors:  David Barrett; Valerie I Brown; Stephan A Grupp; David T Teachey
Journal:  Paediatr Drugs       Date:  2012-10-01       Impact factor: 3.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.